NCT06750692

Brief Summary

The aim of the study is to investigate the comparison of the effects of mirror therapy, Repetitive Transcranial Magnetic Stimulation and robot-assisted hand therapy added to conventional neurological rehabilitation on upper extremity function, quality of life and pain in stroke.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable stroke

Timeline
1mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Dec 2024Jun 2026

First Submitted

Initial submission to the registry

December 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 27, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2026

Expected
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

December 20, 2024

Last Update Submit

March 11, 2026

Conditions

Keywords

Mirror TherapyRepetitive Transcranial Magnetic StimulationHand-Finger Robot

Outcome Measures

Primary Outcomes (1)

  • Fugl Meyer Upper Extremity Assessment Questionnaire

    The Fugl Meyer Upper Extremity Motor Assessment Scale was developed to quantitatively assess sensorimotor recovery after stroke. It was prepared based on Brunnstrom's stages of motor recovery. The FMUE Scale consists of 33 items, each scored from 0 to 2, where 0 = cannot perform, 1 = partially performs, and 2 = fully performs. The total score is 66. A range of data is available for the minimum clinically important differences for the FMUE Scale. A change of 4 to 7 points in chronic stroke, 12 points in subacute stroke, and 9 to 10 points is considered clinically significant.Higher scores indicate better upper limb functional recovery.

    Baseline and Post-treatment (4th week)

Secondary Outcomes (15)

  • Brunnstrom Staging

    Baseline and Post-treatment (4th week)

  • Mini Mental Test

    Baseline

  • Modified Ashworth Scale

    Baseline and Post-treatment (4th week)

  • Box Block Test

    Baseline and Post-treatment (4th week)

  • Nine Hole Peg Test

    Baseline and Post-treatment (4th week)

  • +10 more secondary outcomes

Study Arms (3)

Experimental: Mirror therapy

EXPERIMENTAL

The first group of participants will receive mirror therapy for 4 weeks, 5 sessions per week for a total of 20 sessions of upper extremity mirror therapy.

Other: Procedure: Mirror therapy

Experimental: Low Frequency rTMS Protocol

EXPERIMENTAL

The second group will receive a total of 20 sessions of Repetitive Transcranial Magnetic Stimulation (rTMS) to the contralateral M1 upper extremity motor cortex region at low frequency (1Hz) and intensity of 100%-110% of the resting motor threshold, 5 sessions per week for 4 weeks.

Device: Device: Low Frequency rTMS Protocol

Experimental: Robotic-assisted hand therapy

EXPERIMENTAL

In the Robot Assisted Therapy group, a total of 20 sessions will be applied to the hemiplegic upper extremity with AMADEO (Tyromotion Austria) 5 days a week for 4 weeks.

Device: Robotic-assisted hand therapy

Interventions

The first group of participants will receive a total of 20 sessions of upper extremity mirror therapy program, 5 sessions per week for 4 weeks.

Experimental: Mirror therapy

Repetitive Transcranial Magnetic Stimulation (rTMS) will be applied at an intensity of 100-110% of the resting motor threshold and low frequency (1 Hz) to the contralateral M1 upper extremity motor cortex region for a total of 20 sessions, 5 sessions per week for 4 weeks. rTMS application is planned to provide magnetic stimulation with the stimulator of the Magventure MagPro R30 device.

Experimental: Low Frequency rTMS Protocol

In the Robot Assisted Therapy group, a total of 20 sessions will be applied 5 days a week for 4 weeks using continuous passive range of motion, active assistive exercise and play therapy programs for hemiplegic upper extremities with AMADEO (Tyromotion Austria).

Experimental: Robotic-assisted hand therapy

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Female and male patients between the ages of 40-80
  • stroke at least 3 months ago
  • voluntarily agreed to participate in the study regularly, whose health status is suitable for rehabilitation and who are medically stable
  • mini mental test score of 15 and above
  • Neurologically stable patient
  • significant comorbidities such as serious heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension
  • history of epilepsy, antiepileptic drug use
  • intracranial metal objects
  • intraauricular implants
  • cognitive dysfunction
  • upper extremity peripheral nerve injuries
  • malignancy
  • active infection
  • skin infections or open wounds in the application area
  • inflammatory diseases
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Afyonkarahisar Health Sciences University

Afyonkarahisar, 0300, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Duret C, Grosmaire AG, Krebs HI. Robot-Assisted Therapy in Upper Extremity Hemiparesis: Overview of an Evidence-Based Approach. Front Neurol. 2019 Apr 24;10:412. doi: 10.3389/fneur.2019.00412. eCollection 2019.

    BACKGROUND
  • Jia F, Zhao Y, Wang Z, Chen J, Lu S, Zhang M. Effect of Graded Motor Imagery Combined With Repetitive Transcranial Magnetic Stimulation on Upper Extremity Motor Function in Stroke Patients: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2024 May;105(5):819-825. doi: 10.1016/j.apmr.2023.12.002. Epub 2023 Dec 17.

    PMID: 38110138BACKGROUND
  • Gandhi DB, Sterba A, Khatter H, Pandian JD. Mirror Therapy in Stroke Rehabilitation: Current Perspectives. Ther Clin Risk Manag. 2020 Feb 7;16:75-85. doi: 10.2147/TCRM.S206883. eCollection 2020.

    BACKGROUND

MeSH Terms

Conditions

StrokeNeuralgiaNervous System Diseases

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Selma Eroglu, MD

    Afyonkarahisar Health Sciences University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Selma Eroglu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Single-Blinded Prospective Randomized Trial
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 20, 2024

First Posted

December 27, 2024

Study Start

December 27, 2024

Primary Completion

April 20, 2026

Study Completion (Estimated)

June 20, 2026

Last Updated

March 12, 2026

Record last verified: 2026-03

Locations